Highly Effective Therapies Early in Pediatric MS Linked to Reduced Relapse Risk

Study supports starting kids on high-efficacy drugs, but long-term safety studies are crucial

Related Keywords

France ,Laplaud ,Limousin ,Toronto ,Ontario ,Canada ,French ,Ann Yeh ,Sophie Putka ,Observatoire Fran , ,Medpage Today ,Sick Children ,Wall Street Journal ,Business Insider ,Cannabis Wire ,